Deflazacort 30 mg Tablets – IMFLEC 30

Deflazacort 30 mg Tablets – Strong Defense Against Inflammation & Autoimmune Disorders.

IMFLEC 30 – Deflazacort 30 mg is a glucocorticoid corticosteroid that suppresses the immune system and manages inflammation, muscle weakness, swelling, and pain associated with kidney stones. It works by inhibiting the release of inflammatory mediators (prostaglandins & leukotrienes), thereby reducing inflammation, swelling, and immune overactivity. It also suppresses immune responses, making it useful in treating autoimmune conditions, and also used to treat Duchenne muscular dystrophy (DMD) (a disease that causes muscle weakness).

Recommended by specialists:
✅Rheumatologists – For managing autoimmune and inflammatory disorders like rheumatoid arthritis (RA), lupus, and vasculitis.
✅Neurologists – As a first-line treatment for Duchenne Muscular Dystrophy (DMD) and other neuromuscular conditions.
✅Pulmonologists – Used in chronic respiratory conditions like asthma, COPD, and interstitial lung disease to reduce inflammation.
✅Dermatologists – For severe allergic reactions, eczema, and autoimmune skin disorders like pemphigus.

Key benefits of Deflazacort 30 mg Tablets – IMFLEC 30
✅Dual Action – A potent corticosteroid with high efficacy in reducing inflammation and immune system overactivity.
✅Minimal side effects – Deflazacort has a better safety profile with minimal risk of side effects as compared to methylprednisolone and prednisolone.
✅Versatile Use – Treats various conditions including rheumatoid arthritis, asthma, Duchenne muscular dystrophy (DMD), and Allergic reactions.

Indications
✅Duchenne muscular dystrophy (DMD)
✅Asthma
✅Ulcerative colitis
✅Allergic reactions
✅Rheumatoid arthritis